| | | | | |
ANIK Anika Therapeutics Inc | $21.3900 | +0.61% | $294.82M | $67.22K | |
BACC Blue Acquisition Corp. Class A Ordinary Shares | $10.4850 | +0.05% | $294.73M | $7.10K | |
GPAC General Purpose Acquisition Corp. Class A Ordinary Shares | $10.1200 | +0.80% | $294.68M | $14.28K | |
BPRN Princeton Bancorp, Inc. Common Stock (PA) | $42.5100 | +1.02% | $294.53M | $15.44K | |
| $43.3300 | -0.60% | $294.35M | $6.89K | |
ACGC ACP Holdings Acquisition Corp. Class A Ordinary Shares | $9.9900 | -0.10% | $294.35M | $179.00 | |
HCAC Hall Chadwick Acquisition Corp Class A Ordinary Shares | $10.0800 | +0.00% | $294.33M | $815.00 | |
SLN Silence Therapeutics Plc American Depository Share | $13.1850 | -3.12% | $294.27M | $560.23K | |
MTNE CH4 Natural Solutions Corporation | $9.8950 | +0.05% | $293.88M | $7.000 | |
RXST RxSight, Inc. Common Stock | $6.0950 | -1.06% | $293.64M | $582.13K | |
NHIC NewHold Investment Corp III Class A Ordinary shares | $10.6200 | -0.14% | $293.52M | $581.11K | |
IRHO Iron Horse Acquisitions II Corp. Common Stock | $10.0250 | +0.00% | $293.49M | $639.00 | |
CNXU Conexeu Sciences Inc. Common Stock | $9.3750 | +4.63% | $293.27M | $241.12K | |
| $10.6700 | +3.29% | $292.98M | $1.33M | |
JCE Nuveen Core Equity Alpha Fund | $16.9700 | +0.03% | $292.78M | $15.74K | |
